Clinical Outcomes Following Treatment With Systane® Balance in Dry Eye Subjects
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the superior efficacy of Systane® Balance over
Preservative-Free 0.9% Saline following 35 days of QID (4 times a day) dosing in treating dry
eye subjects with lipid deficiency.